THC Farmaceuticals (CBDG) Stock Statistics & Valuation Metrics
Total Valuation
THC Farmaceuticals has a market cap or net worth of $163.18K. The enterprise value is $314.72B.
- Market Cap
- $163.18K
- Enterprise Value
- $314.72B
Share Statistics
THC Farmaceuticals has 18,131,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 18,131,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
THC Farmaceuticals’s return on equity (ROE) is -0.00 and return on invested capital (ROIC) is -1.09%.
- Return on Equity (ROE)
- -0.00
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -1.09%
- Return on Capital Employed (ROCE)
- -0.01
- Revenue Per Employee
- 0
- Profits Per Employee
- -7,488
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of THC Farmaceuticals is -15.70. THC Farmaceuticals’s PEG ratio is -0.16.
- PE Ratio
- -15.70
- PS Ratio
- 0.00
- PB Ratio
- 0.05
- Price to FCF
- 0.26
- Price to Operating Cash Flow
- 0.26
- PEG Ratio
- -0.16
Income Statement
In the last 12 months, THC Farmaceuticals had revenue of 0 and earned -14.98K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- -4,952
- Operating Income
- -29.95K
- Pretax Income
- -29.95K
- Net Income
- -14.98K
- EBITDA
- -25.00K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -14.99K and capital expenditures 0, giving a free cash flow of -14.99K billion.
- Operating Cash Flow
- -14.99K
- Free Cash Flow
- -14.99K
- Free Cash Flow per Share
- 0.04
Dividends & Yields
THC Farmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 389.46%
- Earnings Yield
- -6.37%
Stock Price Statistics
- Beta
- 0.11
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- 30.99
- Average Volume (3m)
- 212
Financial Position
THC Farmaceuticals as a current ratio of 0.12, with Debt / Equity ratio of 4.42%
- Current Ratio
- 0.12
- Quick Ratio
- 0.12
- Debt to Market Cap
- 0.78
- Net Debt to EBITDA
- -5.59
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, THC Farmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
THC Farmaceuticals EV to EBITDA ratio is -17.58, with an EV/FCF ratio of 0.44.
- EV to Sales
- 0.00
- EV to EBITDA
- -17.58
- EV to Free Cash Flow
- 0.44
- EV to Operating Cash Flow
- 0.44
Balance Sheet
THC Farmaceuticals has $6,869.00 in cash and marketable securities with $386.30K in debt, giving a net cash position of -$379.43K billion.
- Cash & Marketable Securities
- $6,869.00
- Total Debt
- $386.30K
- Net Cash
- -$379.43K
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- $0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for THC Farmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
